Related Experiment Videos
Regulatory mechanisms controlling human E-cadherin gene expression.
Yan-Nan Liu1, Wen-Wen Lee, Chun-Yi Wang
1Graduate Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
Oncogene
|August 24, 2005
Summary
Hepatocyte Nuclear Factor 3 (HNF3) can restore E-cadherin expression in breast cancer cells. This re-expression reduces cancer cell motility and metastatic potential.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- E-cadherin is a crucial tumor suppressor gene.
- Loss of E-cadherin promotes cancer invasion and metastasis by disrupting cell-cell junctions.
Purpose of the Study:
- To investigate the regulation of E-cadherin gene expression in cancer cells.
- To identify transcription factors that modulate E-cadherin expression.
Main Methods:
- Functional analysis of human E-cadherin regulatory sequences.
- Transfection of metastatic breast cancer cells with HNF3.
- Morphological and motility assays (Transwell).
Main Results:
- AML1, Sp1, and p300 are implicated in promoting E-cadherin expression.
- Hepatocyte Nuclear Factor 3 (HNF3) binding sites were identified.
- Exogenous HNF3 enhanced E-cadherin promoter activity and re-expressed E-cadherin in metastatic breast cancer cells.
- HNF3-transfected cells exhibited epithelial morphology and reduced motility.
Conclusions:
- HNF3 plays a significant role in upregulating E-cadherin expression.
- Restoring E-cadherin via HNF3 can decrease the metastatic potential of breast cancer cells.